Gossamer Earnings Yield vs Capex To Operating Cash Flow Analysis

GOSS Stock

USD 0.77 0.05 6.10%

Gossamer Bio financial indicator trend analysis is much more than just examining Gossamer Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gossamer Bio is a good investment. Please check the relationship between Gossamer Bio Earnings Yield and its Capex To Operating Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Earnings Yield vs Capex To Operating Cash Flow

Earnings Yield vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gossamer Bio Earnings Yield account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Gossamer Bio's Earnings Yield and Capex To Operating Cash Flow is -0.82. Overlapping area represents the amount of variation of Earnings Yield that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Gossamer Bio, assuming nothing else is changed. The correlation between historical values of Gossamer Bio's Earnings Yield and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Earnings Yield of Gossamer Bio are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Earnings Yield i.e., Gossamer Bio's Earnings Yield and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.82

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Earnings Yield

The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.

Capex To Operating Cash Flow

Most indicators from Gossamer Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.Enterprise Value is likely to gain to about 613.3 M in 2024, whereas Selling General Administrative is likely to drop slightly above 36.5 M in 2024.

Gossamer Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Total Liab	Total Current Assets	Other Liab	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Net Invested Capital	Net Working Capital	Property Plant And Equipment Net	Other Assets	Net Receivables
Total Assets		0.78	0.93	0.9	-0.6	0.69	-0.27	-0.72	0.83	0.81	0.77	1.0	0.65	0.91	0.7	0.76	1.0	0.92	0.85	0.94	0.2	0.88	1.0	0.89	-0.84	-0.03
Short Long Term Debt Total	0.78		0.87	0.93	-0.67	0.31	0.18	-0.93	0.8	0.58	1.0	0.78	0.79	0.83	0.72	0.78	0.78	0.83	0.95	0.88	0.46	0.76	0.76	0.61	-0.91	-0.52
Other Current Liab	0.93	0.87		0.98	-0.67	0.52	0.03	-0.85	0.71	0.6	0.85	0.93	0.74	0.95	0.74	0.81	0.93	0.96	0.93	0.95	0.28	0.82	0.91	0.79	-0.91	-0.08
Total Current Liabilities	0.9	0.93	0.98		-0.64	0.45	0.12	-0.91	0.76	0.57	0.92	0.9	0.8	0.94	0.75	0.82	0.9	0.94	0.97	0.96	0.38	0.82	0.88	0.73	-0.94	-0.2
Total Stockholder Equity	-0.6	-0.67	-0.67	-0.64		-0.44	0.21	0.46	-0.36	-0.63	-0.67	-0.6	-0.16	-0.51	-0.48	-0.52	-0.6	-0.52	-0.64	-0.51	0.3	-0.58	-0.57	-0.69	0.52	0.16
Net Tangible Assets	0.69	0.31	0.52	0.45	-0.44		-0.53	-0.21	0.46	0.72	0.31	0.69	0.1	0.38	-0.01	0.06	0.69	0.39	0.5	0.57	-0.26	0.83	0.69	0.9	-0.47	0.41
Net Debt	-0.27	0.18	0.03	0.12	0.21	-0.53		-0.43	-0.23	-0.68	0.19	-0.27	0.48	0.06	-0.01	0.01	-0.26	0.06	0.16	0.01	0.66	-0.16	-0.28	-0.4	-0.26	-0.3
Retained Earnings	-0.72	-0.93	-0.85	-0.91	0.46	-0.21	-0.43		-0.7	-0.35	-0.93	-0.72	-0.94	-0.86	-0.67	-0.73	-0.72	-0.86	-0.92	-0.87	-0.68	-0.71	-0.71	-0.51	0.96	0.45
Accounts Payable	0.83	0.8	0.71	0.76	-0.36	0.46	-0.23	-0.7		0.78	0.8	0.84	0.68	0.75	0.68	0.72	0.84	0.76	0.77	0.86	0.45	0.75	0.83	0.6	-0.74	-0.43
Cash	0.81	0.58	0.6	0.57	-0.63	0.72	-0.68	-0.35	0.78		0.57	0.81	0.22	0.56	0.5	0.53	0.81	0.57	0.56	0.65	-0.15	0.74	0.81	0.82	-0.5	-0.14
Long Term Debt	0.77	1.0	0.85	0.92	-0.67	0.31	0.19	-0.93	0.8	0.57		0.77	0.78	0.81	0.71	0.76	0.77	0.81	0.95	0.87	0.46	0.76	0.74	0.6	-0.91	-0.54
Cash And Short Term Investments	1.0	0.78	0.93	0.9	-0.6	0.69	-0.27	-0.72	0.84	0.81	0.77		0.65	0.91	0.7	0.76	1.0	0.92	0.85	0.94	0.2	0.88	1.0	0.89	-0.84	-0.03
Common Stock Shares Outstanding	0.65	0.79	0.74	0.8	-0.16	0.1	0.48	-0.94	0.68	0.22	0.78	0.65		0.84	0.66	0.71	0.66	0.84	0.78	0.81	0.84	0.58	0.65	0.36	-0.88	-0.41
Long Term Debt Total	0.91	0.83	0.95	0.94	-0.51	0.38	0.06	-0.86	0.75	0.56	0.81	0.91	0.84		0.84	0.89	0.91	1.0	0.85	0.93	0.43	0.72	0.91	0.68	-0.88	-0.16
Non Current Liabilities Total	0.7	0.72	0.74	0.75	-0.48	-0.01	-0.01	-0.67	0.68	0.5	0.71	0.7	0.66	0.84		0.99	0.7	0.85	0.61	0.68	0.34	0.35	0.69	0.36	-0.58	-0.4
Total Liab	0.76	0.78	0.81	0.82	-0.52	0.06	0.01	-0.73	0.72	0.53	0.76	0.76	0.71	0.89	0.99		0.76	0.89	0.69	0.75	0.36	0.44	0.74	0.43	-0.66	-0.38
Total Current Assets	1.0	0.78	0.93	0.9	-0.6	0.69	-0.26	-0.72	0.84	0.81	0.77	1.0	0.66	0.91	0.7	0.76		0.92	0.85	0.95	0.2	0.88	1.0	0.88	-0.84	-0.04
Other Liab	0.92	0.83	0.96	0.94	-0.52	0.39	0.06	-0.86	0.76	0.57	0.81	0.92	0.84	1.0	0.85	0.89	0.92		0.86	0.93	0.43	0.73	0.91	0.69	-0.88	-0.16
Capital Surpluse	0.85	0.95	0.93	0.97	-0.64	0.5	0.16	-0.92	0.77	0.56	0.95	0.85	0.78	0.85	0.61	0.69	0.85	0.86		0.95	0.41	0.88	0.82	0.72	-0.96	-0.27
Other Current Assets	0.94	0.88	0.95	0.96	-0.51	0.57	0.01	-0.87	0.86	0.65	0.87	0.94	0.81	0.93	0.68	0.75	0.95	0.93	0.95		0.43	0.89	0.93	0.77	-0.94	-0.15
Other Stockholder Equity	0.2	0.46	0.28	0.38	0.3	-0.26	0.66	-0.68	0.45	-0.15	0.46	0.2	0.84	0.43	0.34	0.36	0.2	0.43	0.41	0.43		0.2	0.21	-0.11	-0.55	-0.55
Net Invested Capital	0.88	0.76	0.82	0.82	-0.58	0.83	-0.16	-0.71	0.75	0.74	0.76	0.88	0.58	0.72	0.35	0.44	0.88	0.73	0.88	0.89	0.2		0.88	0.92	-0.87	-0.03
Net Working Capital	1.0	0.76	0.91	0.88	-0.57	0.69	-0.28	-0.71	0.83	0.81	0.74	1.0	0.65	0.91	0.69	0.74	1.0	0.91	0.82	0.93	0.21	0.88		0.89	-0.83	-0.03
Property Plant And Equipment Net	0.89	0.61	0.79	0.73	-0.69	0.9	-0.4	-0.51	0.6	0.82	0.6	0.89	0.36	0.68	0.36	0.43	0.88	0.69	0.72	0.77	-0.11	0.92	0.89		-0.71	0.19
Other Assets	-0.84	-0.91	-0.91	-0.94	0.52	-0.47	-0.26	0.96	-0.74	-0.5	-0.91	-0.84	-0.88	-0.88	-0.58	-0.66	-0.84	-0.88	-0.96	-0.94	-0.55	-0.87	-0.83	-0.71		0.28
Net Receivables	-0.03	-0.52	-0.08	-0.2	0.16	0.41	-0.3	0.45	-0.43	-0.14	-0.54	-0.03	-0.41	-0.16	-0.4	-0.38	-0.04	-0.16	-0.27	-0.15	-0.55	-0.03	-0.03	0.19	0.28

Click cells to compare fundamentals

Gossamer Bio Account Relationship Matchups

Gossamer Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	426.6M	539.4M	343.7M	272.5M	311.9M	293.4M
Other Current Liab	33.6M	27.5M	33.7M	33.2M	31.2M	24.6M
Total Current Liabilities	36.9M	38.7M	39.9M	49.2M	51.6M	32.7M
Total Stockholder Equity	(334.2M)	(577.5M)	(811.5M)	(1.0B)	62.8M	65.9M
Net Tangible Assets	352.5M	320.7M	121.5M	12.1M	13.9M	13.2M
Net Debt	(95.5M)	(302.3M)	1.8M	113.8M	180.4M	189.4M
Retained Earnings	(334.2M)	(577.5M)	(811.5M)	(1.0B)	(1.2B)	(1.2B)
Accounts Payable	956K	7.5M	3.2M	1.5M	5.5M	2.9M
Cash	135.1M	486.1M	183.4M	112.0M	32.1M	30.5M
Non Current Assets Total	17.3M	17.1M	11.9M	10.6M	5.4M	9.6M
Non Currrent Assets Other	1.6M	1.0M	1.1M	680K	618.0K	923.7K
Cash And Short Term Investments	401.8M	512.6M	325.2M	255.7M	296.4M	277.9M
Common Stock Shares Outstanding	54.7M	68.5M	74.8M	84.6M	152.6M	160.3M
Short Term Investments	266.7M	26.6M	141.8M	143.7M	264.3M	132.9M
Liabilities And Stockholders Equity	(260.1M)	(358.8M)	(589.3M)	(771.9M)	311.9M	327.5M
Non Current Liabilities Total	37.2M	180.1M	182.3M	211.1M	197.5M	158.6M
Total Liab	74.1M	218.7M	222.2M	260.4M	249.1M	191.3M
Total Current Assets	409.3M	522.3M	331.8M	261.9M	306.5M	283.8M
Capital Surpluse	686.4M	897.6M	932.9M	1.0B	1.2B	659.2M
Other Current Assets	7.5M	9.1M	6.5M	6.2M	10.1M	6.7M
Other Stockholder Equity	(426.9M)	(607K)	(53K)	564K	1.3B	1.3B
Net Invested Capital	380.9M	493.1M	300.6M	231.4M	271.8M	244.7M
Net Working Capital	372.4M	483.7M	291.9M	212.7M	254.9M	287.0M
Property Plant And Equipment Net	15.7M	16.1M	10.8M	9.9M	4.8M	8.1M
Other Assets	1.6M	1.0M	1.1M	680K	1.0	0.95
Property Plant And Equipment Gross	15.7M	16.1M	15.1M	16.0M	10.2M	14.0M
Accumulated Other Comprehensive Income	258K	599K	45K	(574K)	(350K)	(332.5K)
Property Plant Equipment	15.7M	5.5M	5.3M	4.0M	3.6M	5.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC